Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-platelet Precision Medicine to Prevent Stroke Early Progression and Recurrence (PRECISE)

NCT03701360 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT03701360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03701360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-platelet Precision Medicine to Prevent Stroke Early Progression and Recurrence (PRECISE)
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Completed
Start date
October 30, 2018
Completion date
July 14, 2021
Enrollment
1,199 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke